Stock SILVAPHL SILVA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Silva Pharmaceuticals Limited

Equities

SILVAPHL

BD0493SPL001

End-of-day quote Dhaka S.E.
Other stock markets
 06:00:00 2024-06-18 pm EDT 		5-day change 1st Jan Change
16.2 BDT 0.00% Intraday chart for Silva Pharmaceuticals Limited +0.62% -25.00%
Apr. 29 Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Jan. 29 Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Silva Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2023
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2022
CI
Silva Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2021
CI
Silva Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2020
CI
Silva Pharmaceuticals Limited Recommends Dividend for the Year Ended on June 30, 2020
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended December 31, 2019
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2019
CI
Silva Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2019
CI
Silva Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019
CI
Silva Pharmaceuticals Limited Announces Unaudited Earnings Results for the Quarter and Half Year Ended December 31, 2018
CI
Silva Pharmaceuticals Limited Announces Audited Earnings Results for the Year Ended June 30, 2018
CI
Silva Pharmaceuticals Limited has completed an IPO in the amount of BDT 300 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SILVAPHL Stock
  4. News Silva Pharmaceuticals Limited